George Klinger

3.0k total citations · 1 hit paper
13 papers, 2.1k citations indexed

About

George Klinger is a scholar working on Cardiology and Cardiovascular Medicine, Pharmaceutical Science and Surgery. According to data from OpenAlex, George Klinger has authored 13 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cardiology and Cardiovascular Medicine, 4 papers in Pharmaceutical Science and 3 papers in Surgery. Recurrent topics in George Klinger's work include Heart Failure Treatment and Management (5 papers), Drug Solubulity and Delivery Systems (4 papers) and Advanced Drug Delivery Systems (3 papers). George Klinger is often cited by papers focused on Heart Failure Treatment and Management (5 papers), Drug Solubulity and Delivery Systems (4 papers) and Advanced Drug Delivery Systems (3 papers). George Klinger collaborates with scholars based in United States, United Kingdom and Denmark. George Klinger's co-authors include Balasamy Thiyagarajan, Bertram Pitt, Felipe A Martinez, Günter A.J. Riegger, Robert Segal, Divakar Sharma, Marvin A. Konstam, Kenneth Dickstein, A. John Camm and James D. Neaton and has published in prestigious journals such as The Lancet, Circulation and Journal of Clinical Oncology.

In The Last Decade

George Klinger

12 papers receiving 2.0k citations

Hit Papers

Effect of losartan compared with captopril on mortality i... 2000 2026 2008 2017 2000 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
George Klinger United States 9 1.5k 464 400 234 210 13 2.1k
Peter Finn United States 21 1.7k 1.1× 565 1.2× 219 0.5× 239 1.0× 293 1.4× 33 3.5k
Joel Neutel United States 20 1.1k 0.8× 518 1.1× 554 1.4× 112 0.5× 203 1.0× 48 1.9k
Robert Glazer United States 26 2.9k 1.9× 533 1.1× 652 1.6× 82 0.4× 229 1.1× 50 3.3k
Michael Klibaner United States 12 1.0k 0.7× 253 0.5× 322 0.8× 258 1.1× 98 0.5× 20 1.4k
N M Agrawal United States 10 634 0.4× 734 1.6× 68 0.2× 216 0.9× 116 0.6× 24 2.8k
John G. Fort United States 21 749 0.5× 1.0k 2.2× 123 0.3× 225 1.0× 205 1.0× 65 2.6k
C. Steven Ernest United States 22 1.4k 0.9× 662 1.4× 452 1.1× 65 0.3× 113 0.5× 41 2.1k
Harry Haber United States 16 1.3k 0.8× 672 1.4× 700 1.8× 355 1.5× 153 0.7× 28 2.2k
Peter H.J.M. Dunselman Netherlands 24 1.7k 1.2× 473 1.0× 134 0.3× 53 0.2× 141 0.7× 57 2.1k
Peter Crean Ireland 26 1.7k 1.1× 842 1.8× 105 0.3× 168 0.7× 249 1.2× 78 2.6k

Countries citing papers authored by George Klinger

Since Specialization
Citations

This map shows the geographic impact of George Klinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Klinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Klinger more than expected).

Fields of papers citing papers by George Klinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George Klinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Klinger. The network helps show where George Klinger may publish in the future.

Co-authorship network of co-authors of George Klinger

This figure shows the co-authorship network connecting the top 25 collaborators of George Klinger. A scholar is included among the top collaborators of George Klinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George Klinger. George Klinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
4.
Warr, David, Paul J. Hesketh, Richard J. Gralla, et al.. (2005). Efficacy and Tolerability of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer After Moderately Emetogenic Chemotherapy. Journal of Clinical Oncology. 23(12). 2822–2830. 370 indexed citations
5.
Pitt, Bertram, Philip A. Poole‐Wilson, Robert Segal, et al.. (2000). Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial—the Losartan Heart Failure Survival Study ELITE II. The Lancet. 355(9215). 1582–1587. 1319 indexed citations breakdown →
6.
7.
Klinger, George, Divakar Sharma, Robert Segal, & Bertram Pitt. (1998). Overall safety and tolerability of losartan in patients with heart failure. Journal of Cardiac Failure. 4(3). 40–40.
8.
Frey, Martin J., et al.. (1996). Effect of aspirin on the acute and chronic hemodynamic response to angiotensin II receptor blockade with losartan in heart failure. Journal of the American College of Cardiology. 27(2). 228–228. 2 indexed citations
9.
Crozier, Ian, Hamid Ikram, Najam A. Awan, et al.. (1995). Losartan in Heart Failure. Circulation. 91(3). 691–697. 217 indexed citations
10.
Klinger, George, et al.. (1990). Formulation of Controlled Release Matrices by Granulation with a Polymer Dispersion. Drug Development and Industrial Pharmacy. 16(9). 1473–1490. 9 indexed citations
11.
Klinger, George, et al.. (1989). Thermal Treatment of Beads with Wax for Controlled Release. Drug Development and Industrial Pharmacy. 15(9). 1311–1328. 35 indexed citations
12.
Klinger, George, et al.. (1989). Modified Drug Release From Beads Prepared with Combinations of Two Grades of Microcrystalline Cellulose. Drug Development and Industrial Pharmacy. 15(9). 1455–1473. 26 indexed citations
13.
Remon, Jean Paul, et al.. (1988). Formation of theophylline monohydrate during the pelletisation of microcrystalline cellulose-anhydrous theophylline blends. International Journal of Pharmaceutics. 42(1-3). 15–18. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026